Paul Knight
Stock Analyst at Keybanc
(2.38)
# 2,633
Out of 5,090 analysts
139
Total ratings
46.09%
Success rate
-1.45%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $281.77 | +24.21% | 12 | Oct 24, 2025 | |
| XGN Exagen | Maintains: Overweight | $12 → $15 | $7.50 | +100.00% | 7 | Oct 14, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $7.76 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $122.02 | +80.30% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $9.80 | +53.06% | 9 | Aug 6, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $113.02 | +19.45% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.73 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $63.37 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $396.37 | +16.05% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.44 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $4.06 | +97.29% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $102.55 | +41.39% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $183.60 | +128.76% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $96.25 | +138.96% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $25.75 | +28.16% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $39.59 | -9.06% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $227.13 | +36.49% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $165.54 | +32.90% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $575.24 | - | 6 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $22.92 | +61.43% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.73 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $4.77 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $148.32 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $35.00 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $11.15 | +258.74% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $184.04 | +63.01% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $224.92 | +11.15% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $118.86 | +271.02% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $142.19 | +65.98% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $77.30 | +28.07% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $11.13 | +394.16% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $47.41 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $77.32 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $127.80 | - | 5 | Oct 23, 2017 |
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $281.77
Upside: +24.21%
Exagen
Oct 14, 2025
Maintains: Overweight
Price Target: $12 → $15
Current: $7.50
Upside: +100.00%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $7.76
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $122.02
Upside: +80.30%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $9.80
Upside: +53.06%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $113.02
Upside: +19.45%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.73
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $63.37
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $396.37
Upside: +16.05%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.44
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $4.06
Upside: +97.29%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $102.55
Upside: +41.39%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $183.60
Upside: +128.76%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $96.25
Upside: +138.96%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $25.75
Upside: +28.16%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $39.59
Upside: -9.06%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $227.13
Upside: +36.49%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $165.54
Upside: +32.90%
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $575.24
Upside: -
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $22.92
Upside: +61.43%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.73
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $4.77
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $148.32
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $35.00
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $11.15
Upside: +258.74%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $184.04
Upside: +63.01%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $224.92
Upside: +11.15%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $118.86
Upside: +271.02%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $142.19
Upside: +65.98%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $77.30
Upside: +28.07%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $11.13
Upside: +394.16%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $47.41
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $77.32
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $127.80
Upside: -